PMID 27019980
It helps enhance nerve health, energy levels, and overall well-being gradually with consistent use under medical supervision
Limit test studies failed to establish an LD50, indicating exceptionally low acute toxicity even at very high doses
Consider whether symptoms might indicate: Underlying conditions being unmasked or worsening Effects of other supplements or medications Lifestyle factors like inadequate sleep, poor nutrition, or excessive stress Infections or illnesses unrelated to peptide use If symptoms do not match the expected AOD 9604 profile, persist after discontinuation, or are accompanied by other concerning signs, investigate independently rather than assuming the peptide is responsible
Vukojevic et al., 2018), produced by amputation, and/or anti-coagulants application, or major vessel occlusion, along with the evidence that pentadecapeptide BPC 157 may prevent and/or attenuate or eliminate, thus, counteracting both arterial thrombosis (Kolovrat et al., 2020) and venous thrombosis (Vukojevic et al., 2018